AI timing and outcomes in heart attack study
Part of Heart & circulation clinical trials.
This trial uses artificial intelligence to analyze ECG results and timing in patients with a type of heart attack called Non-STEMI (where the artery is narrowed but not fully blocked). The goal is to see if AI can help predict damage and outcomes, which could lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- You must have a Non-STEMI heart attack (confirmed by a heart specialist).
- You must not be having a STEMI heart attack (a more severe type).
- Your ECG must be clear and of good quality for digital analysis.
- You must not have a current dangerous heart rhythm (sustained ventricular arrhythmia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artificial intelligence system that helps doctors quickly identify heart attacks (myocardial infarction) in patients with symptoms like chest pain or shortness of breath. It aims to speed up diagnosis and treatment.
This study uses artificial intelligence to look at heart images and data to predict if someone might have a heart attack soon. It aims to help doctors act faster and improve care for people with heart conditions.
This study uses artificial intelligence to predict how heart arteries might change after a stent procedure (PCI). Researchers will collect blood samples and medical data to develop a tool that could help doctors make better treatment decisions.
This trial tests an artificial-intelligence tool that uses a heart ultrasound to help guide stent treatment. It may help doctors choose the best way to treat blockages and improve stent results for people with symptoms from reduced blood flow to the heart.
This trial is testing whether using artificial intelligence to read ECGs in the emergency department helps doctors better manage heart attacks, especially under a new payment system. It may help speed up treatment and improve care.
This study tests whether an AI-powered single-lead ECG (a simple heart tracing) can help detect narrowed coronary arteries. If successful, it could offer a simpler way to screen for heart disease.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.